Triton Biopharma (GREY:TZUGF)

The majority of our treatments for infectious diseases and cancer are natural products based and are either directly sourced from terrestrial plant and soil microbes or, at minimum, the prototype is of natural origin. Triton's focus is to utilize the vast resources of the oceans in the development of the next generation of pharmaceutical products. The structural and biological diversity of the ocean provides a wealth of novel drug leads or drug-like molecules for commercial development. Tapping into this resource, Triton is able to bring new innovation to the Pharmaceutical, Food Products and Biotechnology Industries with the production of marine derived fine chemicals and pharmaceutical products. In addition to its leads in preclinical development, Triton has an inventory of unique marine natural products available for purchase